JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
NU
Nu Holdings Ltd.
NU has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
NU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
NU's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like NU.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
NU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $11.83 | — |
| Current | 16x | $11.83 | — |
| Cheap | 23x | $17.04 | +44% |
| Fair | 33x | $24.31 | +106% |
| Expensive | 125x | $92.38 | +681% |
Historical ranges are pointers, not guarantees.
NU has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
NU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
NU has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
NU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.06 | +43% |
| Q2 2026 | $0.74 | +61% |
| Q1 2026 | $0.65 | +51% |
| Q4 2025 | $0.58 | +45% |
| Q3 2025 | $0.51 | +42% |
| Q2 2025 | $0.46 | +48% |
| Q1 2025 | $0.43 | +65% |
| Q4 2024 | $0.40 | +90% |
| Q3 2024 | $0.36 | +350% |
NU has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over NU on profitability, with a higher operating margin.
NU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.5B | +50% |
| Q1 2026 | $5B | +53% |
| Q4 2025 | $4.7B | +65% |
| Q3 2025 | $4.2B | +46% |
| Q2 2025 | $3.7B | +34% |
| Q1 2025 | $3.2B | +23% |
| Q4 2024 | $2.9B | +24% |
| Q3 2024 | $2.9B | +34% |
NU has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 22% | -1.5 points |
| Q1 2026 | 19% | -5.3 points |
| Q4 2025 | 23% | -3.9 points |
| Q3 2025 | 27% | +1.4 points |
| Q2 2025 | 24% | -2.5 points |
| Q1 2025 | 24% | +2.6 points |
| Q4 2024 | 27% | +2.5 points |
| Q3 2024 | 25% | +6.1 points |
NU's operating margin was 22% last quarter, down 1.5 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over NU on cash flow, with more consistent year-over-year improvement.
NU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9B | -218% |
| Q1 2026 | -$1.3B | -229% |
| Q4 2025 | $1.1B | -14% |
| Q3 2025 | -$1.1B | +$8.8M |
| Q2 2025 | $2.5B | -6.3% |
| Q1 2025 | $1B | +$1.6B |
| Q4 2024 | $1.3B | -52% |
| Q3 2024 | -$1.1B | +$2.2B |
NU's free cash flow was −$4.2B over the past year, against $3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like NU.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over NU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
NU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -5.4M shares |
| 1 year | +0.1% | +5.1M shares |
| 3 years | +1.3% | +61M shares |
| 5 years | +6.4% | +296M shares |
| Available history | +6.4% | +296M shares |
NU has 4.9B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $500.4M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NU spent $500M buying back its own shares over the past year, after none the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over NU on leverage, with a lower net debt burden relative to earnings.
NU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.0x | High |
| Q1 2026 | -3.9x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -3.9x | Net Cash |
| Q2 2025 | -4.6x | Net Cash |
| Q1 2025 | -4.3x | Net Cash |
| Q4 2024 | -4.4x | Net Cash |
| Q3 2024 | -4.3x | Net Cash |
NU's net debt is about 5.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like NU.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
NU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 10.5 | Oversold |
NU's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over NU on valuation relative to its sector.
NU PE vs Financial Services Sector
| Metric | NU | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 23% above |
| PE % | 1 | 63 | 62 pts below |
NU is trading at 16x earnings, a 23% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over NU on trend strength, trading above more of its moving averages.
NU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 13% below |
| 20 week MA | $14.0 | 15% below |
| 50 week MA | $14.6 | 19% below |
| 100 week MA | $13.8 | 14% below |
| 200 week MA | $11.7 | 1.5% above |
NU has fallen below most of its moving averages, though it's still 1.5% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over NU on returns for 2026, with the stronger performance.
NU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.9 | $9.83 | -17% |
| 2022 | $9.83 | $3.89 | -60% |
| 2023 | $3.89 | $8.33 | +114% |
| 2024 | $8.33 | $10.3 | +24% |
| 2025 | $10.3 | $16.8 | +62% |
| 2026 YTD | $16.8 | $11.8 | -29% |
NU's yearly returns have swung widely, from +114% in 2023 to −60% in 2022. It's down 29% so far in 2026.